This new generation of medicines have proved to be efficient in more than 90% of cases
FACUA requests Ministry of Health to explain their actions regarding the purchase of the new medicines for hepatitis C
The organisation asks for a public explanation of how the NHS is dealing with the most serious cases despite the high price of the active ingredient necessary for their therapy. Spain is not in the group of European countries negotiating together to get it cheaper.
FACUA.org
España-26/08/2014
Francisco Sánchez Legrán, president of FACUA-Consumers in Action, has sent a letter to Ana Mato, Minister (Secretary) of Health, requesting what actions has taken the Ministry she runs to deal with the most serious cases of hepatitis C in Spain. The body committed to d
Contenido exclusivo para socios
